Groupe Hospitalier du Havre
Montivilliers, 76290, France
Location status: Recruiting
NCT Number: NCT07837375
Chronic obstructive pulmonary disease (COPD) is associated with dyspnea, reduced physical activity, muscle deconditioning, and impaired quality of life. Pulmonary rehabilitation is an effective non-pharmacological intervention, but access remains limited and long-term adherence to physical exercise is often difficult to maintain. Augmented reality may provide an innovative approach to support exercise practice by offering real-time visual and auditory guidance while allowing patients to remain anchored in their real environment.
The SPARK study is a multicenter, interventional, non-randomized, proof-of-concept study designed to assess the acceptability of an augmented reality virtual coach for physical exercise in adults with COPD. Participants will attend a single experimental session including baseline questionnaires, presentation of the augmented reality headset, a short immersive exercise session guided by a virtual coach, and post-immersion assessments. Acceptability will be evaluated using the Technology Acceptance Model 3 questionnaire before and after immersion. User experience will also be explored through focus group discussions analyzed according to UXive dimensions.
The study aims to determine whether this technology is acceptable to patients with COPD and to identify factors that may facilitate or limit its future integration into pulmonary rehabilitation pathways.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Montivilliers, 76290, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will use an augmented reality headset delivering a virtual coach-guided exercise session. The intervention consists of a single approximately 20-minute immersive session performed in a secured environment. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. The session includes calf raises, sit-to-stand exercises, and stretching. The intervention is designed to assess the acceptability and user experience of an augmented reality-based exercise support tool in adults with chronic obstructive pulmonary disease.
Other names: Augmented Reality Exercise Coach, SPARK Virtual Coach
Time frame: Immediately after the augmented reality immersion session, during the single study visit
Acceptability will be assessed using the global score of the adapted Technology Acceptance Model 3 questionnaire completed immediately after the augmented reality immersion session. Items are rated on a 7-point Likert scale, with higher scores indicating greater acceptability. The mean global score will be compared with the theoretical neutral value of 4.
Contact information is provided by the study sponsor or research team.
Angélique Picard
CONTACT
Clement Medrinal, PhD
CONTACT
Groupe Hospitalier du Havre
Other
Acceptability of an Augmented Reality Virtual Coach for Physical Exercise Practice in Patients With Chronic Obstructive Pulmonary Disease: a Multicenter Study
Acronym: SPARK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06956742
Behavior, Chronic Disease
Rouen, Normandy, France
View Trial DetailsNCT06682832
Behavior, Chronic Disease
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06629675
Behavior, Chronic Disease
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT07792642
Behavior, Chronic Disease
Aveiro, Portugal
View Trial Details